Paid Clinical Trials Delaware
Discover 125 paid clinical trials in Delaware. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Neoadjuvant Chemotherapy vs. ChemoradiotherapyNeoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Sponsor:
Canadian Cancer Trials Group
Location:
Code:
NCT06205485
Conditions
Rectal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Leucovorin
Oxaliplatin
Fluoruracil
Capecitabine
Radiation
ABBV-383A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma
Sponsor:
TeneoOne Inc.
Location:
Code:
NCT05650632
Conditions
Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ABBV-383
REACTA Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Sponsor:
Prokidney
Location:
Code:
NCT05099770
Conditions
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Eligibility Criteria
Sex: All
Age: 30 - 70+
Healthy Volunteers: Not accepted
Interventions
Renal Autologous Cell Therapy (REACT)
Sham Comparator
Disclosure InterventionDisclosure Intervention for People in Treatment for Opioid Use Disorder
Sponsor:
University of Delaware
Location:
Code:
NCT06458985
Conditions
Opioid Use Disorder
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Disclosing Recovery: A Decision Aid and Toolkit
Observational StudyNatural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy
Sponsor:
Tenaya Therapeutics
Location:
Code:
NCT05112237
Conditions
Cardiomyopathy
Eligibility Criteria
Sex: All
Age: 0 - 18
Healthy Volunteers: Not accepted
HMPL-523The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)
Sponsor:
Hutchmed
Location:
Code:
NCT06291415
Conditions
Immune Thrombocytopenia
Blood Platelet Disorder
Hematologic Diseases
Purpura, Thrombocytopenic
Purpura
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
HMPL-523
Ultrasound-facilitated ThrombolysisUltrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism
Sponsor:
Boston Scientific Corporation
Location:
Code:
NCT04790370
Conditions
Pulmonary Embolism
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Anticoagulation with heparin
EkoSonicTM Endovascular System
AnifrolumabPhase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis
Sponsor:
AstraZeneca
Location:
Code:
NCT05138133
Conditions
Lupus Nephritis
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
Anifrolumab
Placebo
Oral & Injectable BuprenorphineA Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
Sponsor:
VA Office of Research and Development
Location:
Code:
NCT04375033
Conditions
Opioid Use Disorder
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sublingual buprenorphine with naloxone
Injectable subcutaneous buprenorphine
Rilvegostomig & PembrolizumabA Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Sponsor:
AstraZeneca
Location:
Code:
NCT06692738
Conditions
Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Rilvegostomig
Pembrolizumab
Carboplatin
Paclitaxel
Nab-paclitaxel